Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: J Biomed Inform. 2010 Jul 7;43(6):932–944. doi: 10.1016/j.jbi.2010.07.001

Table 3.

32 hub genes from DE fundamental components in PTL-treated compared to untreated AML CD34+ cells.*

Connections Gene FC(s)
47 XBP1 84
33 TNF 66
30 LCK 43
25,14,11 CEBPB 192,362,406
21 IL1B 101
18,13 CEBPA 101,406
16 ZAP70 43
15 CNBP 62
15 CD40LG 43
14,11 FOS 62,359
14 IL1A 73
14 IL10 406
14 HGF 406
13 HSPA8 362
13 HLA-B 84
12 HSPA5 84
12 NFKB1 66
11,10 EP300 66,406
11,9 STAT4 66,43
11 HSP90AA1 362
11 LAT 43
11 CD28 43
10 IL15 406
10 CD247 43
10 CD3E 43
9 PTGS2 101
9 EIF3A 62
9 HSP90AB1 362
9 CD2 43
9 VEGFA 79
9 MMP9 79
8 CREM 66
*

Bold indicates a gene that does not appear on the text-mined list and thus represents a potentially novel prediction.